Belinda Lovelace

5PUBLICATIONS
11CO-AUTHORS
Medical mycologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Plant and fungus systematics and taxonomyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2026
Duration of Antifungal Therapy in Disseminated Coccidioidomycosis Patients: A Real-World Treatment Utilization Study.

|Nov 26, 2025
Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018-2023.

Huiqiao Fan, Fariba Donovan, Belinda Lovelace

|Sep 26, 2025
Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis.

Thomas J Walsh, Craig I Coleman, Melissa Johnson

|Aug 27, 2025
Cost-effectiveness of olorofim in the treatment of invasive aspergillosis in patients with limited suitable alternative treatment options: a US payer perspective.

Thomas J Walsh, Craig I Coleman, Rob Blissett

|Feb 16, 2022
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US.

John Fanikos, Joshua N Goldstein, Belinda Lovelace

Pageof 1

Frequent Collaborators

4 joint publications

Craig I Coleman

1 joint publications

John Fanikos

1 joint publications

Joshua N Goldstein

1 joint publications

Anne C Beaubrun